Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals.

MLA

Lederer, Katlyn, et al. “Germinal Center Responses to SARS-CoV-2 MRNA Vaccines in Healthy and Immunocompromised Individuals.” Cell, vol. 185, no. 6, Mar. 2022, p. 1008. EBSCOhost, https://doi.org/10.1016/j.cell.2022.01.027.

APA

Lederer, K., Bettini, E., Parvathaneni, K., Painter, M. M., Agarwal, D., Lundgreen, K. A., Weirick, M., Muralidharan, K., Castaño, D., Goel, R. R., Xu, X., Drapeau, E. M., Gouma, S., Ort, J. T., Awofolaju, M., Greenplate, A. R., Le Coz, C., Romberg, N., Trofe-Clark, J., & Malat, G. (2022). Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell, 185(6), 1008. https://doi.org/10.1016/j.cell.2022.01.027

Chicago

Lederer, Katlyn, Emily Bettini, Kalpana Parvathaneni, Mark M. Painter, Divyansh Agarwal, Kendall A. Lundgreen, Madison Weirick, et al. 2022. “Germinal Center Responses to SARS-CoV-2 MRNA Vaccines in Healthy and Immunocompromised Individuals.” Cell 185 (6): 1008. doi:10.1016/j.cell.2022.01.027.